Evidence map›Paper›PMID 25571880›Full record

ReviewPituitary2015

Clinical and biochemical manifestations of Cushing's.

Georgia Ntali, Ashley Grossman, Niki Karavitaki

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Pituitary, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension.The Journal of clinical endocrinology and metabolism · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Georgia NtaliDepartment of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Rd, Headington, Oxford, OX3 7LJ, UK.
Ashley Grossman
Niki Karavitaki
Churchill Hospital · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCushing's syndrome is associated with a number of clinical manifestations and co-morbidities which may not resolve even after long-term remission leading to excessive mortality. MATERIALS AND

methodsThis review summarizes the main manifestations of Cushing's syndrome (active or in remission) with particular focus on data from recently published literature.

conclusionObesity and metabolic alterations, hypertension and cardio/cerebrovascular complications, hypercoagulability/thromboembolism, neuropsychiatric, muscle/skeletal and immune consequences remain the most challenging. Cardiovascular consequences and immunosuppression determine the main causes of death in Cushing's syndrome necessitating early intervention when possible.

Indexed as

ACTH-Secreting Pituitary AdenomaAdenomaCause of DeathComorbidityHumansPituitary ACTH HypersecretionPrognosisRisk AssessmentRisk FactorsTime Factors

Identifiers

PMID25571880
OpenAlexW2040720487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.